Analytical, Diagnostic and Therapeutic Techniques, and Equipment [E] » Investigative Techniques [E05] » Epidemiologic Methods » Epidemiologic Study Characteristics » Clinical Studies as Topic » Clinical Trials as Topic » Clinical Trials, Phase I as Topic
Health Care [N] » Health Care Quality, Access, and Evaluation [N05] » Quality of Health Care » Health Care Evaluation Mechanisms » Epidemiologic Study Characteristics » Clinical Studies as Topic » Clinical Trials as Topic » Clinical Trials, Phase I as Topic
Health Care [N] » Environment and Public Health [N06] » Public Health » Epidemiologic Methods » Epidemiologic Study Characteristics » Clinical Studies as Topic » Clinical Trials as Topic » Clinical Trials, Phase I as Topic
Description
Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. MeSH
Hierarchy View
Phase 1 Indicated Drugs (3)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
